Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Diversa Corporation (DVSA) -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (24)	11/18/2000 3:54:22 PM
From: kinkblot	Read Replies (1) \| Respond to of 144

Thumbs up from "Up & Down Wall Street" In this week's Barron's, Abelson passes along some thoughts from one of his health-care sources, Larry Feinberg of the Oracle Partners hedge fund, who is very bullish on industrial genomics: ... As we may have intimated, Larry is more than a bit enthusiastic about industrial genomics. When in full spiel, he calls it nothing less than the second Industrial Revolution. Since we missed the first, we must confess we couldn't be more pleased to be present at the sequel. interactive.wsj.com [online subscription required] Specifically mentioned: Genencor (his top pick) and Diversa. He thinks both stocks could hit $50, though no time frame is given. Sounds like Larry is ticked off that his stocks got dragged down by the negative call on biotech in last week's Barron's. WT